Rhonda Cooper-DeHoff, Pharm.D., M.S., an associate professor of pharmacotherapy and translational research and cardiovascular medicine and the associate director of the Center for Pharmacogenomics, was presented with the Russell R. Miller Award on Oct. 23 at the American College of Clinical Pharmacy’s, or ACCP, Annual Meeting in Hollywood, Florida. The award is given in recognition of her substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy. Miller was the founding editor of the ACCP journal, Pharmacotherapy.
Those who nominated Cooper-DeHoff praised her contributions to clinical pharmacy literature. She has published more than 140 peer-reviewed manuscripts, with most appearing in high-impact journals. Her research has focused on hypertension and factors that influence outcomes with antihypertensive treatment. One of her most important literary contributions was a 2010 paper describing cardiovascular outcomes in diabetic patients based on blood pressure control from the INVEST clinical trial. The publication appeared in the Journal of the American Medical Association, or JAMA, and has accrued more than 500 citations.
Cooper-DeHoff has served as an editorial board member for Cardiology Today and is a reviewer for several prestigious journals. She was recognized in 2014 as an ACCP fellow and has earned many national and international awards, including the 2015 ACCP Distinguished Investigator Award for the Cardiology Practice and Research Network and the 2015 Distinguished Associate Award of the American College of Cardiology.